Hilde Morris joins AlgiPharma
Hilde Morris has recently been appointed to replace our outgoing clinical director.
Entries by Philip Rye
AlgiPharma collaboration with Cardiff University wins Medical Innovation Award
AlgiPharma collaboration wins Cardiff University’s prestigious Medical Innovation Award
AlgiPharma Announces $4 Million Award from Cystic Fibrosis Foundation Therapeutics to Advance Clinical Development of OligoG
AlgiPharma Announces $4 Million Award from Cystic Fibrosis Foundation Therapeutics to Advance Clinical Development of OligoG.
AlgiPharma features in CFF drug development pipeline
AlgiPharma now features on the Cystic Fibrosis Foundation (CFF) drug development pipeline
AlgiPharma signs new license agreement with NTNU
AlgiPharma secures new license agreement with NTNU for exclusive global rights.
AlgiPharma granted Orphan Drug designation by FDA
AlgiPharma granted Orphan Drug designation by FDA
